These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drug marketing exclusivity under United States and European Union law. Junod V. Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347 [No Abstract] [Full Text] [Related]
4. The Food and Drug Administration; our mutual responsibility. HOLLAND AH. N Y State J Med; 1955 Aug 15; 55(16):2327-30. PubMed ID: 13244856 [No Abstract] [Full Text] [Related]
11. US Congress to consider limits on DTCA. Guthrie P. CMAJ; 2007 May 08; 176(10):1404. PubMed ID: 17485685 [No Abstract] [Full Text] [Related]
12. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984. Lewis RA. J Contemp Health Law Policy; 1992 May 08; 8():361-78. PubMed ID: 10118987 [No Abstract] [Full Text] [Related]
13. US aims to tighten rules on direct-to-consumer drug ads. Vastag B. Nat Biotechnol; 2007 Mar 08; 25(3):267. PubMed ID: 17344868 [No Abstract] [Full Text] [Related]
14. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers. Soehnge H. Food Drug Law J; 2003 Mar 08; 58(1):51-80. PubMed ID: 12739584 [No Abstract] [Full Text] [Related]
18. Navigating the Hatch-Waxman Act's safe harbor. Jones PB. Food Drug Law J; 2002 Mar 08; 57(3):475-89. PubMed ID: 12710407 [No Abstract] [Full Text] [Related]
19. Pediatric Research Equity Act. J Natl Cancer Inst; 2004 Dec 15; 96(24):1810. PubMed ID: 15601636 [No Abstract] [Full Text] [Related]
20. Understanding the regulation of pharmaceutical drug promotion [Editorial]. Krane NA, Sataloff RT. Ear Nose Throat J; 2014 Dec 15; 93(12):486-8. PubMed ID: 25531838 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]